MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease

    G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)

    Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2020

    How Parkinson’s Disease Affects Working Memory

    L. Montaser Kouhsari, A. Bakkour, D. Shohamy (New York, NY, USA)

    Objective: Our study designed to (1) measure working memory via verbal Digit Span in Parkinson’s patients without mild cognitive impairment (MCI) (2) determine how dopaminergic…
  • MDS Virtual Congress 2020

    Gender differenes in cognitive functioning in de novo Parkinson’s disease patients

    A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar (Groningen, Netherlands)

    Objective: To clarify the differences in cognitive functioning across different cognitive domains, between male and female de novo PD patients. Background: Parkinson’s disease (PD) is…
  • MDS Virtual Congress 2020

    Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

    P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: This study explores the value of α-Syn, Aβ1-42, t-tau, p-tau181 in cerebrospinal fluid(CSF) and their ratios for the diagnosis of Parkinson's disease with mild…
  • MDS Virtual Congress 2020

    First clinical and genetic analysis of LRRK2 G2019S, R1441G/C/H/, I2020T and Y1699C mutations in Costa Rican patients with Parkinson’s disease

    A. Hernandez-Guillen, T. Lobo-Prada, J. Ruiz-Martinez, A. Gorostidi-Pagola, Z. Gan-Or, K. Carazo-Cespedes, J. Fornaguera-Trias, G. Torrealba-Acosta (San José, Costa Rica)

    Objective: To assess the frequency of G2019S, R1441G/C/H, I2020T and Y1699C mutations in a Costa Rican cohort of Parkinson’s disease (PD) cases and controls. Background:…
  • MDS Virtual Congress 2020

    Whole-exome sequencing in early-onset Parkinson’s disease among ethnic Chinese

    N. Li, L. Wang, J. Zhang, E. Tan, J. Li, J. Peng, L. Duan, C. Chen, D. Zhou, L. He, R. Peng (Chengdu, China)

    Objective: The objectives of this study were to assess the genetic and clinical features of early-onset Parkinson’s disease (EOPD) among ethnic Chinese from mainland China.…
  • MDS Virtual Congress 2020

    The First-Ever CNV Analysis in Latin American Parkinson’s Disease Patients

    E.I Sarihan, E. Pérez-Palma, L.M Niestroj, D. Loesch, M. Seyfi, M. Inca-Martinez, A. Horimoto, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H.B Ferraz, C. Rieder, A. Schumacher-Schuh, B.L Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C.E Arboleda-Bustos, D. Yearout, C.P Zabetian, T. Thornton, T.D O’Connor, D. Lal, I.F Mata (Cleveland, OH, USA)

    Objective: To assess the CNV burden in a cohort of Latin American Parkinson’s disease (PD) patients and controls. Background: Despite the fact that PD prevalence…
  • MDS Virtual Congress 2020

    ADAM10 polymorphisms are not associated with susceptibility to Parkinson’s disease and Parkinson’s disease with cognitive impairment in a Chinese cohort

    P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: This study is to explore the relationship between the rs442495 and rs593742 loci of ADAM10 gene and Parkinson's disease( PD) or PD cognitive impairment.…
  • MDS Virtual Congress 2020

    The Fragile X Mental Retardation Protein is lost prior to the appearance of Lewy pathology in Parkinson’s disease

    T. Koeglsperger, Y. Tan, C. Sgobio, T. Arzberger, F. Machleid, Q. Tang, E. Findeiss, J. Tost, T. Chakroun, P. Gao, M. Höllerhage, K. Bötzel, J. Herms, G. Höglinger (Evry Cedex, France)

    Objective: The degeneration of dopaminergic (DA) substantia nigra pars compacta (SNc) neurons is a pathological hallmark of Parkinson's disease (PD). Cell death in PD is…
  • MDS Virtual Congress 2020

    Profile of miRNA expression in CSF of Parkinson’s disease identifies miR-409-3p regulating the apoptosis of dopamine neurons

    X.L Tan, J.Q Tan, F.Y Ming, LL. Lv, H.N Zhang, B.S Tang, W.Q Yan, RR. Bai, X.K Peng, Q.L Xiao, C.Y Wang (Changsha, China)

    Objective: To improve the precise diagnosis of PD at early stage requires more feasible and objective methods. MicroRNA (miRNA) was believed to be a potential…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley